samedan logo
 
 
spacer
home > ict > our clients
OUR CLIENTS
<><><><><><><><><><><><><><><><><><><><><><><> 

Helvoet Pharma
helvoetpharma.com/en

Almac
http://www.almacgroup.com/
 
 
Bormioli Rocco
http://www.bormiolirocco.com/

Brecon Pharmaceuticals
http://www.brecon-pharm.co.uk/


BASF
http://www.corporate.basf.com/
Burkert
http://www.buerkert.com/

Cool Logistics
http://www.cool-logistics.com/

Domino Printing
www.domino-printing.com/uk

Fisher Scientific
http://www.fisher.co.uk/
IMA
http://www.ima.it/

Ingenia Technology
http://www.ingeniatechnology.com/
JDSU
http://www.jdsu.com/

Maxim Pharmaceuticals

Patheon
http://www.patheon.com/

QunetiQ
http://www.qinetiq.com/

Sun Chemical
http://www.sunchemical.com/

Sofrigam
http://www.sofrigam.com/

Weiler
http://www.weilercorp.com/

Ypsomed
http://www.ypsomed.com/
Soft Box Systems
http://www.softboxsystems.co.uk/

SigPack
sigpackinternationallive.screenlight.ch/eng/index.asp
Bosch
http://www.bosch.de/
Safechem
http://www.safechem.co.uk/
Rexam
http://www.rexam.com/

Pill Protect
http://www.pillprotect.com/

Aesica
http://www.aesica-pharma.co.uk/

Bag HealthCare
http://www.bag-healthcare.com/

Bang & Olufsen
http://www.bang-olufsen.com/

Solvay
http://www.solvay.com/

Sensitech
http://www.sensitech.com/
HPA
http://www.hpa.org.uk/

CurTec
http://www.curtec.com/

SMi
http://www.smi-online.co.uk/

spacer
Edited by
Dr Graham Hughes
Consultant in
Pharmaceutical
Development

Published quarterly in
February, May,
August and November
 
Industry Events

BIO-Europe Spring 2018

12-14 March 2018, RAI Amsterdam, Europaplein, NL 1078 GZ, Amsterdam

BIO-Europe Spring® is the springtime counterpart to EBD Group’s flagship conference, BIO-Europe®, and continues the tradition of providing life science companies with high caliber partnering opportunities. Featuring EBD Group’s sophisticated, web-based partnering system, partneringONE®, the event enables delegates to efficiently identify, meet and get partnerships started with companies across the life science value chain, from large biotech and pharma companies to financiers and innovative startups.
More info >>

 
News and Press Releases

Charles River Laboratories Makes Investments in High-Throughput Screening Infrastructure

WILMINGTON, Mass.--(BUSINESS WIRE)--Feb. 1, 2018-- Charles River Laboratories International, Inc. (NYSE: CRL) today announced a new agreement which grants Charles River commercial access to AstraZeneca’s (NYSE: AZN) high-throughput screening (HTS) and compound management infrastructure. Through the agreement, Charles River will perform HTS programs for its clients utilizing AstraZeneca’s state-of-the-art HTS facility.
More info >>

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement